MustGrow Biologics (TSE:MGRO)
:MGRO
Want to see TSE:MGRO full AI Analyst Report?
Total Valuation
MustGrow Biologics has a market cap or net worth of C$33.55M. The enterprise value is C$33.21M.
Market CapC$33.55M
Enterprise ValueC$33.21M
Share Statistics
MustGrow Biologics has 58,854,360 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding58,854,360
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
MustGrow Biologics’s return on equity (ROE) is -8.37 and return on invested capital (ROIC) is -430.85%.
Return on Equity (ROE)-8.37
Return on Assets (ROA)-2.35
Return on Invested Capital (ROIC)-430.85%
Return on Capital Employed (ROCE)-6.14
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover2.68
Inventory Turnover3.44
Valuation Ratios
The current PE Ratio of MustGrow Biologics is ―. MustGrow Biologics’s PEG ratio is -0.13.
PE Ratio―
PS Ratio4.13
PB Ratio39.49
Price to Fair Value39.49
Price to FCF-5.22
Price to Operating Cash Flow-6.63
PEG Ratio-0.13
Income Statement
In the last 12 months, MustGrow Biologics had revenue of 8.29M and earned -7.26M in profits. Earnings per share was -0.13.
Revenue8.29M
Gross Profit1.41M
Operating Income-6.25M
Pretax Income-7.26M
Net Income-7.26M
EBITDA-6.20M
Earnings Per Share (EPS)-0.13
Cash Flow
In the last 12 months, operating cash flow was -5.06M and capital expenditures -1.51M, giving a free cash flow of -6.57M billion.
Operating Cash Flow-5.06M
Free Cash Flow-6.57M
Free Cash Flow per Share-0.11
Dividends & Yields
MustGrow Biologics pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.45
52-Week Price Change-38.04%
50-Day Moving Average0.56
200-Day Moving Average0.63
Relative Strength Index (RSI)52.68
Average Volume (3m)27.52K
Important Dates
MustGrow Biologics upcoming earnings date is Aug 20, 2026, During Market Hours (Confirmed).
Last Earnings DateMay 21, 2026
Next Earnings DateAug 20, 2026
Ex-Dividend Date―
Financial Position
MustGrow Biologics as a current ratio of 1.48, with Debt / Equity ratio of 67.37%
Current Ratio1.48
Quick Ratio0.51
Debt to Market Cap0.02
Net Debt to EBITDA0.05
Interest Coverage Ratio-19.97
Taxes
In the past 12 months, MustGrow Biologics has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
MustGrow Biologics EV to EBITDA ratio is -5.47, with an EV/FCF ratio of -5.17.
EV to Sales4.09
EV to EBITDA-5.47
EV to Free Cash Flow-5.17
EV to Operating Cash Flow-6.70
Balance Sheet
MustGrow Biologics has C$918.77K in cash and marketable securities with C$584.13K in debt, giving a net cash position of C$334.63K billion.
Cash & Marketable SecuritiesC$918.77K
Total DebtC$584.13K
Net CashC$334.63K
Net Cash Per Share<C$0.01
Tangible Book Value Per ShareC$0.02
Margins
Gross margin is 17.33%, with operating margin of -75.45%, and net profit margin of -87.58%.
Gross Margin17.33%
Operating Margin-75.45%
Pretax Margin-87.58%
Net Profit Margin-87.58%
EBITDA Margin-74.84%
EBIT Margin-75.45%
Analyst Forecast
The average price target for MustGrow Biologics is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast1981.95%
EPS Growth Forecast-40.13%